Navigation Links
In Vitro Study of Adamas Pharmaceuticals' Triple Combination Antiviral Drug Therapy Shows Activity Against Drug-Resistant Influenza Viruses
Date:9/13/2009

e antiviral therapy for serious influenza infections, with the potential to address the current limitations of antiviral potency and drug resistance."

The study results showed that the triple combination was highly synergistic in vitro, and the synergy of TCAD therapy was significantly greater than the synergy of double combinations against both susceptible and resistant viruses. Importantly, the study revealed that oseltamivir and amantadine in the triple combination contributed to antiviral activity against oseltamivir-resistant and amantadine-resistant viruses, respectively, at concentrations where they had no activity as single agents, and at concentrations that are clinically relevant.

According to the study investigators, virtually all clinical isolates of seasonal influenza in 2009 have been found to be resistant to either the adamantanes or oseltamivir. They caution that the development of resistance to currently recommended therapies may undermine their utility. While currently limited in scope, the first cases of multi-drug resistant novel influenza A/H1N1 flu are also now being reported and will need to be addressed.(1)

"Drug resistant seasonal influenza and emerging cases of multi-drug resistant novel influenza A/H1N1 virus are creating an immediate need for alternative strategies to currently available antiviral therapies," said Gregory Went, Ph.D., Chief Executive Officer and Chairman of Adamas. "The impact to the healthcare system as a result of increased admissions for those with serious flu is exacerbated during a pandemic so we believe our work is very timely. "

The CDC and WHO recommend the use of antiviral drugs for treating serious cases of influenza infection(2). Antiviral drugs that are both potent and effective against drug-resistant strains also may be important for limiting transmission of the swine flu virus during the pandemic.(3)

The da
'/>"/>

SOURCE Adamas Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
3. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
4. Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against MRSA, VRE and Other Strains of Resistant Bacteria
5. MatTeks EpiDerm In Vitro Tissues Headed for Validation in Europe
6. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
7. New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria
8. Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  SI-BONE, Inc. ( San Jose, California ... use of the iFuse Implant System, ® a ... the sacroiliac (SI) joint, announced that Priority Health ( ... Lumbar Fusion Medical Policy No. 91590-R4 providing positive coverage ... states that the fusion procedure, which employs the iFuse ...
(Date:8/21/2014)... , Aug. 21, 2014   Auxilium ... a specialty biopharmaceutical company, today announced positive results ... collagenase clostridium histolyticum (or CCH) for the treatment ... cellulite. In the Phase 2a trial, all three ... high (0.84mg)) showed an improvement in the appearance ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Indiana blocked the sale of ...
Breaking Medicine Technology:SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... FAIRFIELD, N.J., Jan. 28, 2011 The Healthcare ... of the Year" is Freda Lewis-Hall, MD, chief medical ... Dr. Lewis-Hall has held leadership roles in direct ... (Photo: http://photos.prnewswire.com/prnh/20110128/DC38263 ) ...
... 2011 TechniScan (OTC Bulletin Board: TSNI ... and commercialization of an automated 3D breast ultrasound imaging ... will present at RetailInvestorConferences.com. DATE: , February 3rd, ... This will be a live, interactive online event where ...
Cached Medicine Technology:Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomen's Association 2Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomen's Association 3Pfizer Chief Medical Officer Freda Lewis-Hall Named 2011 Woman of the Year by The Healthcare Businesswomen's Association 4TechniScan to Present Live, Online at RetailInvestorConferences.com on February 3rd 2
(Date:8/21/2014)... born at a low birth weight puts black women at ... The findings may partly explain high diabetes rates among ... low birth weight, the researchers added. Their study of ... low birth weight were 13 percent more likely to develop ... The risk of diabetes was 40 percent higher in those ...
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. ... and antidepressants appears to best help people with severe ... out of five people suffering from severe depression for ... with cognitive therapy plus antidepressant medication, researchers found. ... better than drugs alone in helping people with mild ...
(Date:8/21/2014)... 2014 Transvaginal mesh lawsuits ... to move forward in the federal multidistrict litigation ... West Virginia, Bernstein Liebhard LLP reports. According to ... Court has established new stipulated evidence preservation protocols ... storage and preservation. (In re C.R. Bard Inc. ...
(Date:8/21/2014)... Seattle, WA chiropractors Dr. Lincoln Kamell ... and Massage Center have recently welcomed two new ... Lang, LMP and Mike Larios, LMP have specialized training ... and have developed their expertise working in a variety ... in a clinical environment where massage is used on ...
(Date:8/21/2014)... communities do not routinely screen women for intimate ... and public health researchers. Rural women who are ... they seek help., "Rural health care providers are ... McCall-Hosenfeld, a primary care physician and assistant professor ... College of Medicine. "However, in rural settings, it ...
Breaking Medicine News(10 mins):Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 2Health News:Talk Therapy Plus Meds May Be Best for Severe Depression 3Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 2Health News:Seattle’s Eastlake Chiropractic and Massage Center Is Pleased to Introduce Rina Lang and Mike Larios as New Members of Its Massage Therapy Team 3Health News:Primary care physicians can be critical resource for abused women in rural areas 2
... , TUESDAY, Dec. 6 (HealthDay News) -- U.S. officials ... controversial, unapproved and illegally labeled HCG weight loss products from ... hormone made by the human placenta and found in the ... conjunction with an extremely low-calorie diet -- as low as ...
... legacy of innovative research and commitment to patient-centered ... University and GE Healthcare have announced the commercial ... Veo, that enables physicians to diagnose patients with ... levels. CT is an advanced form of ...
... federally funded report to compare children with special health care ... of children in the United States have a special health ... greater scope of care they require for optimal health. ... A Portrait of States and the Nation 2007, provides an ...
... HealthDay Reporter , TUESDAY, Dec. 6 (HealthDay News) ... an adaptation that not only ups their "yuck" factor but ... studies find. Entomologists from North Carolina State University did ... buildings in North Carolina and New Jersey. Their analysis showed ...
... , TUESDAY, Dec. 6 (HealthDay News) -- A ... been identified by scientists, but they don,t know if people ... or other health problems. Researchers in the Netherlands studied ... and low levels of triglycerides, a type of fat that ...
... observed that only a small percentage of alcoholics develop ... alcoholic liver disease (ALD); the reason why all alcoholics ... The present study from Spain, that includes original work ... levels of glutathione-S-transferases (GST) relate to the risk of ...
Cached Medicine News:Health News:FDA Targets Homeopathic Weight Loss Products 2Health News:FDA Targets Homeopathic Weight Loss Products 3Health News:FDA Targets Homeopathic Weight Loss Products 4Health News:Notre Dame, Purdue and GE Healthcare partner on new CT technology 2Health News:Notre Dame, Purdue and GE Healthcare partner on new CT technology 3Health News:Health care, home, school differ for children with special health care needs 2Health News:Bed Bugs Can Bypass Pitfalls of Inbreeding, Studies Say 2Health News:Bed Bugs Can Bypass Pitfalls of Inbreeding, Studies Say 3Health News:Gene Mutation Helps Clear Fats From Blood, Study Finds 2
5L...
... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
... Family includes fixed-volume, adjustable-volume, and multichannel ... Eppendorf Research pro Pipette. Designed with ... high-performance pipettes have earned a worldwide ... use with original Eppendorf pipette tips, ...
10L...
Medicine Products: